AllNewsPhotosVideos
Rituximab

Rituximab

Rituximab, Latest News

Rituximab, sold under the brand name Rituxan, is a medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.
Read More
94% of patients with cancer respond well to Covid vax: Study - Hindi News | 94% of patients with cancer respond well to Covid vax: Study | Latest health News at Lokmattimes.com

Health :94% of patients with cancer respond well to Covid vax: Study

New York, July 3 Nearly 95 per cent of people with cancer developed a good immune response to ... ...